שולי רווח תפעולי: Sol-Gel Technologies Ltd. (SLGL)

Sol-Gel Technologies (SLGL) operates in the resilient dermatology segment, where demand remains independent of seasonality and economic cycles. The operating margin distribution demonstrates current financial stability, with the -1224.70 metric serving as the target level. The company is implementing innovative microencapsulation to treat rosacea, leveraging stable contract manufacturing operations and updated logistics.
פילוחי מדדים פיננסיים ומדדי שוק עבור Sol-Gel Technologies (SLGL)

Investors utilize profitability multiples to verify business resilience against external shocks and market volatility. Analyzing the operating margin before taxes and interest allows for an assessment of the profit share of revenue, which is critically important for Sol-Gel Technologies (SLGL) amid intense pressure from cheap generics and the risks of restricted insurance payouts in the dermatology sector.